Dolutegravir & abacavir & lamivudine (Triumeq)
- BNF:
- 5.3.1
- Status:
- Red
- Decision Date:
- December 2014
Comments
RED: HIV infection in adults and adolescents aged 12 years and older
NHS England drug - to be used in line with NHS England commissioning intentions
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again